Signaling pathways
-
BA9081 MRT-14Summary: MRT-14 is a potent antagonist. -
BA9082 IHR-1Summary: An antagonist. -
BA9083 SRI-011381Summary: An activator of a signaling pathway having oral biological activity. -
BA9084 LuspaterceptSummary: Luspatercept (ACE-536) is a recombinantly modified ActRIIB fusion protein that binds to transforming growth factor beta superfamily ligands. -
BA9085 SJ000063181Summary: SJ000063181 is a potent signaling activator, ≤1μM. -
BA9086 TrabedersenSummary: Trabedersen (AP12009) is an antisense oligodeoxynucleotide that specifically inhibits (TGF-beta/Smad). -
BA9087 MongersenSummary: Mongersen (GED-0301) is an antisense oligonucleotide with specific and oral activity. -
BA9089 ALK5-IN-34Summary: ALK5-IN-34 is a selective activin receptor-like kinase (ALK) inhibitor with oral activity. -
BA9090 AdavivintSummary: Adavivint (SM04690; Lorecivivint) is a potent, selective inhibitor of typical signaling pathways. -
BA9091 KYA1797KSummary: KYA1797K is a potent, selective inhibitor.

